Response of metastatic melanoma with a rare BRAF V600K mutation to dabrafenib and trametinib
Melanoma Res
.
2022 Apr 1;32(2):124-127.
doi: 10.1097/CMR.0000000000000773.
Authors
Christian Kromer
1
,
Lyubomira D Vlahova
1
,
Katharina Julius
1
,
Viktor Schnabel
1
,
Michael P Schön
1
2
,
Kirsten Reuter-Jessen
3
,
Ali Seif Amir Hosseini
4
,
Lutz Kretschmer
1
Affiliations
1
Department of Dermatology, Venereology, and Allergology, University Medical Center, Göttingen.
2
Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen.
3
Department of Pathology, University Medical Center and.
4
Department of Diagnostic and Interventional Radiology, University Medical Center Göttingen, Germany.
PMID:
35254334
DOI:
10.1097/CMR.0000000000000773
No abstract available
Publication types
Letter